When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

When drugmakers pulled the weight-loss drug fen-phen off the market in 1997, my mom was devastated. Not because the FDA ...

His time in service has informed his key values: commitment, tirelessness, perfectionism, and discipline. When he’s not ...

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 463.56% and ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s ...

Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...

Ozempic doesn't just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food ...

Professor Joseph Balagtas explained how drugs like Ozempic impact appetite. Purdue’s Center for Food Demand Analysis and ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

How Ozempic is being misused and worsening eating disorders - IN FOCUS: Olivia Petter talks to experts who say that people ...